Summary

• The Sustainable Value Strategy underperformed its benchmark, the Russell 2500 Value Index, in the first quarter.
• Plexus was the top contributor in the first quarter. The company reported a very solid fiscal Q2, with strength coming in all segments.
• Haemonetics Corporation was the top detractor in the first quarter (after being the top contributor in the fourth quarter of 2025).

Strategy Overview / Performance Summary

The Sustainable Value Strategy underperformed its benchmark, the Russell 2500 Value Index, in the first quarter. Quarterly underperformance was driven entirely by stock selection, while sector allocation contributed positively. While we are disappointed with the

13 Followers